Rosuvastatin Tablet, Film Coated
Product Images NDC 68071-3847

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin (NDC 68071-3847). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3847 2)

Rosuvastatin 20 mg film-coated tablets manufactured by NuCare Pharmaceuticals, Inc. The label shows a bottle with 120 tablets. Each round, biconvex, pink tablet is debossed with 'SG' on one side and '118' on the other. The label includes NDC 68071-3847-2 and storage instructions to keep at 68-77°F. Rx only.*

FDA Label Image

Figure-01 (Figure 1)

A cumulative incidence line graph comparing placebo and Rosuvastatin (Rosuva) groups over approximately 5 years. The y-axis shows cumulative incidence percentage, and the x-axis shows time in years. The graph includes hazard ratio (HR 0.56, 95% CI 0.46-0.69) and significance level (P<0.001). A risk table below shows the number of participants at risk at various time points for RSV and placebo groups.*

FDA Label Image

Figure-02 (Figure 2)

A data table presenting clinical study endpoints comparing Rosuvastatin 20 mg to Placebo 20 mg. It includes the number of events and event rates per 1000 patient-years for endpoints such as primary endpoint (MCE), cardiovascular death, nonfatal stroke, nonfatal MI, hospitalized unstable angina, and arterial revascularization. Hazard Ratios with 95% confidence intervals and corresponding P values are shown, alongside a graphical hazard ratio plot.*

FDA Label Image

Figure-02 (Figure 3)

A box plot chart showing percent change from baseline in LDL-C for four statins—Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin—at varying doses. The vertical axis represents percent change, ranging from 0 to -75. Each drug's effect is shown at doses of 10, 20, and 40 mg, with Atorvastatin and Simvastatin also including 80 mg doses. The chart compares LDL-C reduction efficacy across doses and drugs.*

FDA Label Image

Structural Formula (Rosuvastatin Str)

Chemical structure of rosuvastatin calcium, depicting the molecule's arrangement including the fluorophenyl group, sulfonamide, and calcium ion components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.